Press Releases | Medtronic

Month Year

Email alerts

Mar 29, 2014

Medtronic CoreValve® System Results Superior to Open-Heart Surgery at One Year in U.S. Pivotal Trial

CoreValve High Risk Study: FDA Determines Expert Panel Not Required

MINNEAPOLIS and WASHINGTON - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the CoreValve® System showed results superior to surgical aortic valve replacement (SAVR) at one...
Mar 29, 2014

Medtronic Releases Results of SYMPLICITY HTN-3

Medtronic Commits to Further Clinical Investigation and Determining Path Forward for Next U.S. IDE with FDA

MINNEAPOLIS and WASHINGTON, DC - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the full results of the SYMPLICITY HTN-3 clinical trial, which were presented today in late-breaking...
Mar 28, 2014

AORN Foundation, Covidien Team to Offer New Tools for Emerging Nurse Leaders

DENVER, Colo. and DUBLIN, Ireland – March 28, 2014 – In a move aimed at giving nursing professionals the tools they need to address rapidly changing practices and cost structures, the AORN...
Mar 27, 2014

First Patients Enrolled in Medtronic Clinical Study Designed to Identify Patients at High Risk for Sudden Cardiac Arrest in Developing Countries

Study Will Assess Defibrillator Therapy in Patients Most At-Risk for SCA

Minneapolis - March 27, 2014 -Medtronic, Inc. (NYSE:MDT) today announced the first patients were enrolled in the Improve SCA Clinical Study, a first-of-its-kind study that will identify patients...
Mar 25, 2014

Study Published in JAMA Shows Covidien Endoscopic Ablation Therapy Effective In Treating Barrett’s Esophagus

DUBLIN--(BUSINESS WIRE)--Mar. 25, 2014-- An innovative Covidien (NYSE: COV) technology is effective at treating Barrett’s esophagus (a precancerous condition of the esophagus), according to a...
Mar 19, 2014

Covidien Declares Quarterly Cash Dividend

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE:COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...
Mar 19, 2014

Covidien Announces Results from 2014 Annual General Meeting

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE: COV) announced the results from today’s Annual General Meeting. Seven proposals were on the meeting agenda: Election of...
Mar 14, 2014

Covidien plc to Report Second-Quarter Fiscal 2014 Results on April 25, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 14, 2014-- Covidien plc (NYSE: COV) will report second-quarter fiscal 2014 results on April 25. The company will host a conference call for investors at 8:30...
Mar 13, 2014

Covidien Launches Symbotex™ Composite Mesh for Surgical Laparoscopic and Open Ventral Hernia Repair

Innovative Mesh Designed to Simplify Surgeon Experience, Offer Patients Optimal Hernia Repairs

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 13, 2014-- Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite...
Mar 10, 2014

Medtronic Seeking Long-Distance Runners Who Benefit From Medical Technology

"Global Heroes" Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October

MINNEAPOLIS - March 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today applications are open to runners around the world who benefit from medical technology to represent their country on the...

Show per page